Benefits & Executive Compensation News
View and Filter All Stories

Latest Stories

AbbVie Unit to Face Antitrust Trial on Alzheimer’s Drug Patent

AbbVie Inc. unit Forest Laboratories and another drug company lost their bid Friday to head off an antitrust trial in federal court in Manhattan over their alleged scheme to delay generic versions of the Alzheimer’s disease treatment Namenda through unlawful patent settlements.

View More